ERK and Akt signaling pathways are involved in advanced glycation end product-induced autophagy in rat vascular smooth muscle cells

International Journal of Molecular Medicine

Volumn 29, Issue 4, 2012, Pages 613-618

  Hu, Pengfei ^a   Lai, Dongwu ^a   Lu, Peilin ^a   Gao, Jing ^b   He, Hong ^a  

^a ZHEJIANG UNIVERSITY   (China)

^b THE THIRD PEOPLE S HOSPITAL OF HANGZHOU   (China)

Author keywords

Advanced glycation end products; Atherosclerosis; Autophagy; Receptor for advanced glycation end products; Vascular smooth muscle cells

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ADVANCED GLYCATION END PRODUCT RECEPTOR; MAMMALIAN TARGET OF RAPAMYCIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN KINASE B; SOMATOMEDIN C; STRESS ACTIVATED PROTEIN KINASE;

ANIMAL CELL; ARTICLE; AUTOPHAGOSOME; AUTOPHAGY; CELL PROLIFERATION; CONTROLLED STUDY; ELECTRON MICROSCOPY; IMMUNOFLUORESCENCE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; RNA INTERFERENCE; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; AUTOPHAGY; CELL LINE; CELL PROLIFERATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GENE EXPRESSION REGULATION; GLYCOSYLATION END PRODUCTS, ADVANCED; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROTO-ONCOGENE PROTEINS C-AKT; RATS; SIGNAL TRANSDUCTION;

EID: 84858249608     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2012.891     Document Type: Article

References (29)

1. Yamagishi S, Takeuchi M, Inagaki Y, Nakamura K and Imaizumi T: Role of advanced glycation end products (AGEs) and their receptor (RAGE) in the pathogenesis of diabetic micro-angiopathy. Int J Clin Pharmacol Res 23: 129-134, 2003. (Pubitemid 38821763)
2. Kilhovd BK, Berg TJ, Birkeland KI, Thorsby P and Hanssen KF: Serum levels of advanced glycation end products are increased in patients with type 2 diabetes and coronary heart disease. Diabetes Care 22: 1543-1548, 1999. (Pubitemid 29418253)
3. Barlovic DP, Soro-Paavonen A and Jandeleit-DahmKA: RAGE biology, atherosclerosis and diabetes. Clin Sci (Lond) 121: 43-55, 2011.
4. Dzau VJ, Braun-Dullaeus RC and Sedding DG: Vascular proliferation and atherosclerosis: New perspectives and therapeutic strategies. Nat Med 8: 1249-1256, 2002. (Pubitemid 35373556)
5. Sakata N, Meng J and Takebayashi S: Effects of advanced glycation end products on the proliferation and fibronectin production of smooth muscle cells. J Atheroscler Thromb 7: 169-176, 2000.
6. Bucciarelli LG, Wendt T, Qu W, et al: RAGE blockade stabilizes established atherosclerosis in diabetic apolipoprotein E-null mice. Circulation 106: 2827-2835, 2002. (Pubitemid 35396983)
7. Bu DX, Rai V, Shen X, et al: Activation of the ROCK1 branch of the transforming growth factor-beta pathway contributes to RAGE-dependent acceleration of atherosclerosis in diabetic ApoE-null mice. Circ Res 106: 1040-1051, 2010.
8. Klionsky DJ: Autophagy: from phenomenology to molecular understanding in less than a decade. Nat Rev Mol Cell Biol 8: 931-937, 2007.
9. Yorimitsu T and Klionsky DJ: Autophagy: molecular machinery for self-eating. Cell Death Differ 12 (Suppl 2): 1542-1552, 2005. (Pubitemid 41553991)
10. Mizushima N and Yoshimori T: How to interpret LC3 immunoblotting. Autophagy 3: 542-545, 2007. (Pubitemid 350060049)
11. Martinet W, Schrijvers DM, Timmermans JP and Bult H: Interactions between cell death induced by statins and 7-keto-cholesterol in rabbit aorta smooth muscle cells. Br J Pharmacol 154: 1236-1246, 2008. (Pubitemid 351992056)
12. Kiffin R, Bandyopadhyay U and Cuervo AM: Oxidative stress and autophagy. Antioxid Redox Signal 8: 152-162, 2006. (Pubitemid 43324542)
13. Heymann D: Autophagy: A protective mechanism in response to stress and inflammation. Curr Opin Investig Drugs 7: 443-450, 2006.
14. Codogno P, Pattingre S and Bauvy C: Amino acids interfere with the ERK1/2-dependent control of macroautophagy by controlling the activation of Raf-1 in human colon cancer HT-29 cells. J Biol Chem 278: 16667-16674, 2003. (Pubitemid 36799530)
15. Chiu HW, Ho SY, Guo HR and Wang YJ: Combination treatment with arsenic trioxide and irradiation enhances autophagic effects in U118-MG cells through increased mitotic arrest and regulation of PI3K/Akt and ERK1/2 signaling pathways. Autophagy 5: 472-483, 2009.
16. Hou FF, Chertow GM, Kay J, et al: Interaction between beta 2-microglobulin and advanced glycation end products in the development of dialysis related-amyloidosis. Kidney Int 51: 1514-1519, 1997. (Pubitemid 27239906)
17. Mitsiades CS, Mitsiades N, Poulaki V, et al: Activation of NF-kappaB and upregulation of intracellular anti-apoptotic proteins via the IGF-1/Akt signaling in human multiple myeloma cells: therapeutic implications. Oncogene 21: 5673-5683, 2002. (Pubitemid 35333000)
18. Creager MA, Goldin A, Beckman JA and Schmidt AM: Advanced glycation end products - Sparking the development of diabetic vascular injury. Circulation 114: 597-605, 2006. (Pubitemid 44199649)
19. Yoon YW, Kang TS, Lee BK, et al: Pathobiological role of advanced glycation endproducts via mitogen-activated protein kinase dependent pathway in the diabetic vasculopathy. Exp Mol Med 40: 398-406, 2008.
20. Kawano M, Koshikawa T, Kanzaki T, Morisaki N, SaitoY and Yoshida S: Diabetes mellitus induces accelerated growth of aortic smooth muscle cells: association with overexpression of PDGF beta-receptors. Eur J Clin Invest 23: 84-90, 1993. (Pubitemid 23056955)
21. Taniguchi N, Kaneto H, Asahi M, et al: Involvement of glycation and oxidative stress in diabetic macroangiopathy. Diabetes 45 (Suppl 3): 81-83, 1996.
22. Basta G, Lazzerini G, Del Turco S, Ratto GM, Schmidt AM and De Caterina R: At least 2 distinct pathways generating reactive oxygen species mediate vascular cell adhesion molecule-1 induction by advanced glycation end products. Arterioscler Thromb Vasc Biol 25: 1401-1407, 2005. (Pubitemid 40923359)
23. Xu B, Chibber R, Ruggiero D, Kohner E, Ritter J and Ferro A: Impairment of vascular endothelial nitric oxide synthase activity by advanced glycation end products. FASEB J 17: 1289-1291, 2003.
24. Miyata T, Hori O, Zhang J, et al: The receptor for advanced glycation end products (RAGE) is a central mediator of the interaction of AGE-beta2microglobulin with human mononuclear phagocytes via an oxidant-sensitive pathway. Implications for the pathogenesis of dialysis-related amyloidosis. J Clin Invest 98: 1088-1094, 1996. (Pubitemid 26299919)
25. Yamamoto Y, Yamagishi S, Hsu CC and Yamamoto H: Advanced glycation endproducts-receptor interactions stimulate the growth of human pancreatic cancer cells through the induction of platelet-derived growth factor-B. Biochem Biophys Res Commun 222: 700-705, 1996. (Pubitemid 26194815)
26. Shintani T and Klionsky DJ: Autophagy in health and disease: a double-edged sword. Science 306: 990-995, 2004. (Pubitemid 39482894)
27. Kockx MM, De Meyer GR, Buyssens N, Knaapen MW, BultH and Herman AG: Cell composition, replication, and apoptosis in atherosclerotic plaques after 6 months of cholesterol withdrawal. Circ Res 83: 378-387, 1998. (Pubitemid 28389967)
28. Lander HM, Tauras JM, Ogiste JS, Hori O, Moss RA and Schmidt AM: Activation of the receptor for advanced glycation end products triggers a p21(ras)-dependent mitogen-activated protein kinase pathway regulated by oxidant stress. J Biol Chem 272: 17810-17814, 1997. (Pubitemid 27311222)
29. Huttunen HJ, Fages C and Rauvala H: Receptor for advanced glycation end products (RAGE)-mediated neurite outgrowth and activation of NF-kappa B require the cytoplasmic domain of the receptor but different downstream signaling pathways. J Biol Chem 274: 19919-19924, 1999.